HALL LAURIE J TRUSTEE - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1
-100.0%
85
-34.6%
0.00%
-100.0%
Q3 2022$2,000
+100.0%
130
+44.4%
0.00%
Q2 2022$1,0000.0%900.0%0.00%
Q1 2022$1,0000.0%900.0%0.00%
Q4 2021$1,0000.0%900.0%0.00%
Q3 2021$1,000
-66.7%
90
-35.7%
0.00%
-100.0%
Q2 2021$3,0000.0%1400.0%0.00%0.0%
Q1 2021$3,0000.0%1400.0%0.00%0.0%
Q4 2020$3,000
-50.0%
1400.0%0.00%
-66.7%
Q3 2020$6,000
-50.0%
140
+40.0%
0.00%
-50.0%
Q4 2019$12,000
+140.0%
100
+25.0%
0.01%
+100.0%
Q3 2019$5,000
+25.0%
80
+60.0%
0.00%
+50.0%
Q2 2019$4,000
-33.3%
500.0%0.00%
-33.3%
Q1 2019$6,0000.0%500.0%0.00%0.0%
Q4 2018$6,000
-25.0%
50
-16.7%
0.00%
-25.0%
Q3 2018$8,000
+60.0%
600.0%0.00%
+33.3%
Q2 2018$5,000
+25.0%
600.0%0.00%
+50.0%
Q1 2018$4,0000.0%600.0%0.00%0.0%
Q4 2017$4,000600.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders